» Articles » PMID: 38861204

Development of Fatty Liver Disease Model Using High Cholesterol and Low Choline Diet in White Leghorn Chickens

Overview
Journal Vet Res Commun
Publisher Springer
Date 2024 Jun 11
PMID 38861204
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD), which shows similar symptoms as fatty liver hemorrhage syndrome (FLHS) in chickens, is the most common cause of chronic liver disease and cancer in humans. NAFLD patients and FLHS in chickens have demonstrated severe liver disorders when infected by emerging strains of human hepatitis E virus (HEV) and avian HEV, respectively. We sought to develop a fatty liver disease chicken model by altering the diet of 3-week-old white leghorn chickens. The high cholesterol, and low choline (HCLC) diet included 7.6% fat with additional 2% cholesterol and 800 mg/kg choline in comparison to 5.3% fat, and 1,300 mg/kg choline in the regular diet. Our diet induced fatty liver avian model successfully recapitulates the clinical features seen during NAFLD in humans and FLHS in chickens, including hyperlipidemia and hepatic steatosis, as indicated by significantly higher serum triglycerides, serum cholesterol, liver triglycerides, cholesterol, and fatty acids. By developing this chicken model, we expect to provide a platform to explore the role of lipids in the liver pathology linked with viral infections and contribute to the development of prophylactic interventions.

Citing Articles

Goose Deoxycholic Acid Ameliorates Liver Injury in Laying Hens with Fatty Liver Hemorrhage Syndrome by Inhibiting the Inflammatory Response.

Wang N, Li W, Ouyang G, Li H, Yang J, Wu G Int J Mol Sci. 2025; 26(1.

PMID: 39796282 PMC: 11721051. DOI: 10.3390/ijms26010429.

References
1.
Bergen W, Mersmann H . Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. J Nutr. 2005; 135(11):2499-502. DOI: 10.1093/jn/135.11.2499. View

2.
Caldwell S, Lee V, Kleiner D, Al-Osaimi A, Argo C, Northup P . NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol. 2009; 8(4):346-52. PMC: 8381243. View

3.
Cole L, Vance J, Vance D . Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim Biophys Acta. 2011; 1821(5):754-61. DOI: 10.1016/j.bbalip.2011.09.009. View

4.
Corbin K, Zeisel S . Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol. 2011; 28(2):159-65. PMC: 3601486. DOI: 10.1097/MOG.0b013e32834e7b4b. View

5.
Cotter T, Rinella M . Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020; 158(7):1851-1864. DOI: 10.1053/j.gastro.2020.01.052. View